Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cassandra Calabrese

Showing results (41-50 of 70) with videos related to

Pageof 7
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)|September 3, 2016
Herpes Zoster and the Risk of Stroke in Patients With Autoimmune DiseasesLeonard H Calabrese, Fenglong Xie, Huifeng Yun, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 16, 2025
The National Academies' 2024 Diagnostic Criteria for Long COVID: Concerns That Could Affect the Rheumatology CommunityLeonard H Calabrese, Michael Putman, Jeffrey A Sparks, et al.
RMD Open|September 19, 2022
Early experience with tixagevimab/cilgavimab pre-exposure prophylaxis in patients with immune-mediated inflammatory disease undergoing B cell depleting therapy and those with inborn errors of humoral immunityCassandra Calabrese, Elizabeth Kirchner, Alexandra Villa-Forte, et al.
Annals of the Rheumatic Diseases|January 20, 2019
Addressing immune-related adverse events of cancer immunotherapy: how prepared are rheumatologists?Marie Kostine, Laura C Cappelli, Cassandra Calabrese, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 24, 2025
Effectiveness of Nirmatrelvir/Ritonavir or Molnupiravir Use in Immunocompromised Patients on B-Cell-Depleting Therapy With COVID-19: A Target Trial Emulation StudyCassandra Calabrese, Yifan Wang, Abhijit Duggal, et al.
Journal of Graduate Medical Education|June 23, 2017
A Professionalism Curricular Model to Promote Transformative Learning Among ResidentsCecile M Foshee, Ali Mehdi, S Beth Bierer, et al.
The American Journal of Medicine|July 8, 2017
Resident-Led Handoffs Training for Interns: Online Versus Live Instruction with Subsequent Skills AssessmentElizabeth Hill, Richard H Cartabuke, Neil Mehta, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 2, 2020
Tocilizumab therapy in 5 solid and composite tissue transplant recipients with early ARDS due to SARS-CoV-2Jose A Morillas, Francisco Marco Canosa, Pavithra Srinivas, et al.
ESC Heart Failure|November 1, 2024
Long-term cardiovascular outcomes of immune checkpoint inhibitor-related myocarditis: A large single-centre analysisLorenzo Braghieri, Ahmad Gharaibeh, Lubika Nkashama, et al.
Annals of the Rheumatic Diseases|August 8, 2020
SARS CoV-2 infection among patients using immunomodulatory therapiesKevin L Winthrop, Amanda E Brunton, Susan Beekmann, et al.
Pageof 7

Showing results (41-50 of 70) with videos related to

Sort By:
Pageof 7
Arthritis & Rheumatology (Hoboken, N.J.)|September 3, 2016
Herpes Zoster and the Risk of Stroke in Patients With Autoimmune DiseasesLeonard H Calabrese, Fenglong Xie, Huifeng Yun, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 16, 2025
The National Academies' 2024 Diagnostic Criteria for Long COVID: Concerns That Could Affect the Rheumatology CommunityLeonard H Calabrese, Michael Putman, Jeffrey A Sparks, et al.
RMD Open|September 19, 2022
Early experience with tixagevimab/cilgavimab pre-exposure prophylaxis in patients with immune-mediated inflammatory disease undergoing B cell depleting therapy and those with inborn errors of humoral immunityCassandra Calabrese, Elizabeth Kirchner, Alexandra Villa-Forte, et al.
Annals of the Rheumatic Diseases|January 20, 2019
Addressing immune-related adverse events of cancer immunotherapy: how prepared are rheumatologists?Marie Kostine, Laura C Cappelli, Cassandra Calabrese, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 24, 2025
Effectiveness of Nirmatrelvir/Ritonavir or Molnupiravir Use in Immunocompromised Patients on B-Cell-Depleting Therapy With COVID-19: A Target Trial Emulation StudyCassandra Calabrese, Yifan Wang, Abhijit Duggal, et al.
Journal of Graduate Medical Education|June 23, 2017
A Professionalism Curricular Model to Promote Transformative Learning Among ResidentsCecile M Foshee, Ali Mehdi, S Beth Bierer, et al.
The American Journal of Medicine|July 8, 2017
Resident-Led Handoffs Training for Interns: Online Versus Live Instruction with Subsequent Skills AssessmentElizabeth Hill, Richard H Cartabuke, Neil Mehta, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 2, 2020
Tocilizumab therapy in 5 solid and composite tissue transplant recipients with early ARDS due to SARS-CoV-2Jose A Morillas, Francisco Marco Canosa, Pavithra Srinivas, et al.
ESC Heart Failure|November 1, 2024
Long-term cardiovascular outcomes of immune checkpoint inhibitor-related myocarditis: A large single-centre analysisLorenzo Braghieri, Ahmad Gharaibeh, Lubika Nkashama, et al.
Annals of the Rheumatic Diseases|August 8, 2020
SARS CoV-2 infection among patients using immunomodulatory therapiesKevin L Winthrop, Amanda E Brunton, Susan Beekmann, et al.
Pageof 7